ArticleJournal of hematology & oncology2017

Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells.

Francesca Megiorni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.